Amanote Research

Amanote Research

    RegisterSign In

Golimumab for the Treatment of Ulcerative Colitis

Expert Opinion on Biological Therapy - United Kingdom
doi 10.1080/14712598.2017.1327576
Full Text
Open PDF
Abstract

Available in full text

Categories
Drug DiscoveryClinical BiochemistryPharmacology
Date

May 16, 2017

Authors
Mathurin FlamantStephane PaulXavier Roblin
Publisher

Informa UK Limited


Related search

Treatment for Ulcerative Colitis

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
2010English

Treatment of Ulcerative Colitis

JAMA - Journal of the American Medical Association
Medicine
1959English

Treatment of Ulcerative Colitis

BMJ
1966English

Letter: Effectiveness of Golimumab to Induce Remission in Outpatient Ulcerative Colitis in Italy

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2016English

The Medical Treatment of Ulcerative Colitis.

Postgraduate Medical Journal
Medicine
1968English

Comparative Efficacy and Safety of Golimumab, Infliximab and Adalimumab for the Treatment of Moderate to Severe Ulcerative Colitis: A Bayesian Indirect Treatment Comparison Meta-Analysis

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Surgical Treatment of Chronic Ulcerative Colitis

BMJ
1952English

IV. Treatment of Severe Ulcerative Colitis

Nippon Daicho Komonbyo Gakkai Zasshi
1978English

Late Results in the Treatment of Ulcerative Colitis

Annals of Surgery
Surgery
1946English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy